Friday, July 10, 2026

Drug profile · INN

diethylstilbestrol diphosphate

diethylstilbestrol diphosphate (STILPHOSTROL) is a estrogen receptor agonist. Route of administration: injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — diethylstilbestrol diphosphate
US status
approved
Class
Route
INJECTION
Patents
0
Programs
0
Data quality
0.84

Quick answer

diethylstilbestrol diphosphate (STILPHOSTROL) is a estrogen receptor agonist. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN diethylstilbestrol diphosphate
Brand STILPHOSTROL
Mechanism Estrogen receptor agonist
Target Estrogen receptor
Route INJECTION
Formulation INJECTABLE

Mechanism of action

Estrogen receptor agonist

Primary target: Estrogen receptor

Approval history

Authority Status Date
FDA approved

Related & competitor drugs

  1. estradiol Estrogen receptor alpha agonist
  2. estradiol valerate Estrogen receptor alpha agonist
  3. estrogens, conjugated synthetic a Estrogen receptor agonist
  4. estropipate Estrogen receptor alpha agonist
  5. ethinyl estradiol Estrogen receptor alpha agonist
  6. fulvestrant Antineoplastic and immunomodulating agents (L02)

Frequently asked questions

What is diethylstilbestrol diphosphate?

diethylstilbestrol diphosphate (STILPHOSTROL) is a estrogen receptor agonist. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for diethylstilbestrol diphosphate?

STILPHOSTROL is a marketed brand name for diethylstilbestrol diphosphate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of diethylstilbestrol diphosphate?

diethylstilbestrol diphosphate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.